Thursday, January 29, 2015

Geriatric medicine and elderly health – the overall market review

Big Market Research adds a report titled “Geriatric Medicine Development - Carving out New Opportunities to Treat Age-related Diseases.” The report provides extensive knowledge of the Market dynamics and forecast the growth potentials of the geriatric medicine development market.

Geriatric medicine or Geriatrics is a field of medical science that specializes with the health care and related concerns of elderly people. Geriatrics promotes health and well- being of the elderly and aims to prevent and treat the older adults with their disabilities and diseases.

The report on geriatric medicine states that almost 50% or more prescriptions are written for people with 65 years of age or older. The statistics shows that on an average one person under this age category intakes at least five drugs on daily basis. The data further states that the consumption of more medicines on daily basis leads to ADEs i.e. adverse drug events among the elders and one third of emergencies among the elderly people is reported to be drug related.

Clinical data lacks in terms of prescriptions and medicines being clinically approved for the elderly people. There is less availability of drugs or medicines with formulations that suit the health conditions of the elderly, which further leads to therapeutics inefficacy and non-compliance.

The report on the geriatric medicine development market provides an in-depth analysis of the market trends and various factors influencing the growth of the market across various geographical regions around the globe.

The report consists of detail explanation regarding assessing entry barriers to geriatric medicines approval and also evaluates the possible ways, which could help in overcoming the challenges and facilitate effective clinical decision making.

The report consists of detail analysis of the various elements of the overall geriatric market and provides insightful information on the same along with leading players across the geriatric medicine development market.

No comments:

Post a Comment